NORMAL SITUATION

Pharmacie du Perron

Company — Normal situation.

Financial year 2023 · Closed on 31/12/2023

Net result54,9 k €+45,0 %over 1 year
Revenue46,9 k €+0,3 %over 1 year
Equity1,1 M €+5,4 %over 1 year

Identity

Source · BCE/KBO

Pharmacie du Perron is a company registered in Belgium.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0402.353.624
Legal form
Private limited company
Contributed capital
18 592,01 €
Latest accounts
31/12/2023
Joint committees (1)
  • 313
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 48 filings

Trend over 18 financial years

20232022202120202019
Income statement
Revenue46,9 k €46,8 k €52,4 k €––
EBITDA43,8 k €44,1 k €45,5 k €-34,1 k €59,4 k €
Operating result41,2 k €40,6 k €42 k €-39,5 k €54,2 k €
Net result54,9 k €37,9 k €34,7 k €-39,3 k €41,1 k €
Balance sheet
Equity1,1 M €1 M €974,8 k €940,1 k €979,4 k €
Total assets1,1 M €1 M €981,3 k €962,1 k €1,2 M €
Cash102,4 €640,4 €2,4 k €3,4 k €744,9 k €
Debts11,2 k €7,9 k €5,7 k €22 k €201 k €
Other
Workforce–––2,0 ETP3,0 ETP

Board of directors

Source · NBB, accounts to 31/12/2023

2 active · 13 ended

Active mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by Hélène GORRIA

Active
UNIVERSAL PHARMA

Director · since 01 septembre 2020 · 0447.382.113

Represented by Pierre HECQ

Active

Ended mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by Marc BREYER

Ended
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by MARC BREYER

Ended
Gladice CLERDENT

Director · until 01 septembre 2020

Ended
Gladice CLERDENT

Director

Ended

Full financial information

Source · NBB
202320222021202020192018
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202301/01/202201/01/202101/01/202001/01/201901/01/2018
Closing of the financial year31/12/202331/12/202231/12/202131/12/202031/12/201931/12/2018
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date14/05/202425/04/202328/11/202205/05/202129/04/202009/04/2019
General meeting29/04/202424/04/202325/04/202226/04/202117/03/202027/03/2019
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 48 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202329/04/202414/05/2024FrenchPDF
Abridged model31/12/202224/04/202325/04/2023FrenchPDF
Abridged modelCorrection31/12/202125/04/202228/11/2022FrenchPDF
Abridged model31/12/202125/04/202229/04/2022FrenchPDF
Abridged model31/12/202026/04/202105/05/2021FrenchPDF
Abridged model31/12/201917/03/202029/04/2020FrenchPDF
Abridged model31/12/201827/03/201909/04/2019FrenchPDF
Abridged model31/12/201708/05/201822/06/2018FrenchPDF
Abridged model31/12/201627/09/201729/09/2017FrenchPDF
Abridged model31/12/201516/05/201730/05/2017FrenchPDF
Abridged model31/12/201427/06/201628/06/2016FrenchPDF
Abridged model31/12/201306/03/201512/03/2015FrenchPDF
Abridged model31/12/201227/12/201330/12/2013FrenchPDF
Abridged model31/12/201129/11/201214/12/2012FrenchPDF
Abridged model31/12/201022/12/201130/12/2011FrenchPDF
Abridged model31/12/200930/12/201031/12/2010FrenchPDF
Abridged model31/12/200830/12/200931/12/2009FrenchPDF
Abridged model31/12/200729/12/200830/12/2008FrenchPDF
Abridged model31/12/200629/12/200731/12/2007FrenchPDF
Abridged model31/12/200528/12/200629/12/2006FrenchPDF
Abridged model31/12/200422/12/200523/12/2005FrenchPDF
Abridged model31/12/200322/12/200429/12/2004FrenchPDF
Abridged model31/12/200210/12/200318/12/2003FrenchPDF
Abridged model31/12/200129/11/200230/12/2002FrenchPDF

View all 48 filings

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2023

2 active · 13 ended

Active mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by Hélène GORRIA

Active
UNIVERSAL PHARMA

Director · since 01 septembre 2020 · 0447.382.113

Represented by Pierre HECQ

Active

Ended mandates

PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by Marc BREYER

Ended
PHARMACIES POPULAIRES DE VERVIERS ET ARRONDISSEMENT

Director · since 01 septembre 2020 · 0402.307.894

Represented by MARC BREYER

Ended
Gladice CLERDENT

Director · until 01 septembre 2020

Ended
Gladice CLERDENT

Director

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Dissolution23/07/2024
    RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
    PDF
  • Restructuring27/05/2024
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates31/05/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Other21/05/2021
    DIVERS
    PDF
  • Mandates09/09/2020
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - MODIFICATION FORME JURIDIQUE - SIEGE SOCIAL - DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE
    PDF
  • Mandates06/09/2017
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates05/03/2012
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2023
    Annual accounts 202354,9 k €↑
  2. 2022
    Annual accounts 202237,9 k €↑
  3. 2021
    Annual accounts 202134,7 k €↑
  4. 2020
    Annual accounts 2020-39,3 k €↓
  5. 2019
    Annual accounts 201941,1 k €↓
  6. 2018
    Annual accounts 201842,9 k €↓
  7. 2017
    Annual accounts 2017207,9 k €↑
  8. 2016
    Annual accounts 201623,2 k €↑
  9. 2015
    Annual accounts 201517,3 k €↓
  10. 2014
    Annual accounts 201485 k €↓
  11. 2013
    Annual accounts 201386,6 k €↑
  12. 2012
    Annual accounts 201285,2 k €↓
  13. 2011
    Annual accounts 201199 k €↑
  14. 2010
    Annual accounts 201062 k €↓
  15. 2009
    Annual accounts 200965,6 k €↑
  16. 2008
    Annual accounts 20086,1 k €↑
  17. 2007
    Annual accounts 2007821,9 €↑
  18. 2006
    Annual accounts 2006-4,3 k €